Verily, Vanderbilt to test enrollment in U.S. Precision Medicine pilot
The pilot program, which aims to enroll 79,000 U.S. participants by the end of this year, is the first phase of an ambitious program to mine medical data, including genetics, environmental factors and lifestyle, to develop better ways to treat or even prevent a wide range of diseases. Vanderbilt and Verily are slated to test approaches for engaging and enrolling volunteers through a web portal. The NIH plans for the “cohort program” to recruit by 2019 one million or more U.S. volunteers – including a wide spectrum of diverse participants from all age, economic and racial groups.
